Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2023
DOI: 10.1016/j.matcom.2022.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Mathematical modeling of tumor growth and treatment: Triple negative breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Despite significant efforts to develop models that predict slower tumor growth in the late stages, recent studies have suggested growth that is even faster than exponential growth [132]. More details of ODEs in tumor growth can be found in [111,[133][134][135][136]. Recently, a thorough investigation was undertaken to compare the outcomes of six ODE models, including the exponential, logistic, 6) [130,131] classic Bertalanffy, general Bertalanffy, classic Gompertz, and general Gompertz models.…”
Section: Continuum Models For Tumor Growthmentioning
confidence: 99%
“…Despite significant efforts to develop models that predict slower tumor growth in the late stages, recent studies have suggested growth that is even faster than exponential growth [132]. More details of ODEs in tumor growth can be found in [111,[133][134][135][136]. Recently, a thorough investigation was undertaken to compare the outcomes of six ODE models, including the exponential, logistic, 6) [130,131] classic Bertalanffy, general Bertalanffy, classic Gompertz, and general Gompertz models.…”
Section: Continuum Models For Tumor Growthmentioning
confidence: 99%
“…These treatment response models have been developed to predict response of cancer cells to different treatment strategies [33][34]. Additionally, these models aim to optimize treatment schedules by identifying optimal and combination regimens, thus improving treatment outcomes [35][36][37]. Several mathematical models have been validated in preclinical studies and trials, demonstrating their potential in designing successful clinical trials [38][39][40][41][42][43][44].…”
Section: Mathematical Models For Cap Treatment Response In Cancermentioning
confidence: 99%